Sg3 Management, LLC Protagonist Therapeutics, Inc Call Options Transaction History

Sg3 Management, LLC

  • $0
  • Q3 2023

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$7.06 - $25.52 $52,950 - $191,400
7,500 Added 6.22%
128,000 $1.01 Million
Q1 2022

May 16, 2022
BUY
$23.34 - $36.08 $1.7 Million - $2.63 Million
73,000 Added 153.68%
120,500 $2.85 Million
Q4 2021

Feb 15, 2022
BUY
$17.63 - $37.1 $308,525 - $649,250
17,500 Added 58.33%
47,500 $1.63 Million
Q3 2021

Nov 15, 2021
BUY
$12.95 - $49.69 $388,500 - $1.49 Million
30,000 New
30,000 $532,000

Others Institutions Holding PTGX

# of Institutions
247
Shares Held
56.4M
Call Options Held
76.3K
Put Options Held
114K
View Full List

About Protagonist Therapeutics, Inc

PTGX Quotes by TradingView
  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $2B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email